Related Experiment Video

Updated: Jul 23, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K

Effectiveness of monovalent and bivalent COVID-19 vaccines

Thiago Cerqueira-Silva1, Viviane S Boaventura2, Manoel Barral-Netto2

  • 1Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil.

The Lancet. Infectious Diseases
|July 15, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.3K
Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

1.9K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.8K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K
Cross-reactivity00:42

Cross-reactivity

Overview
31.3K